Dr. Angel Ojeda, M.D. Obstetrics & Gynecology - Gynecology Medicare: Not Enrolled in Medicare Practice Location: 15921 E 8 Mile Rd, Eastpointe, MI 48021 Phone: 586-774-4480 Fax: 586-774-4190 |
News Archive
WellSpan Health and CareFusion, a BD company, today announced the successful implementation of the Alaris System across all four WellSpan hospitals, with WellSpan York Hospital becoming the first hospital ever to simultaneously go-live with new infusion devices and bi-directional interoperability between the infusion device and the electronic health record (EHR).
Ever since he was a presidential candidate, President Donald Trump has been promising the American people a "terrific," "phenomenal" and "fantastic" new health care plan to replace the Affordable Care Act.
Novartis announced today that the European Commission approved once-daily Ultibro® Breezhaler® (indacaterol 85 mcg / glycopyrronium 43 mcg) as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). In addition, the Japanese Ministry of Health, Labour and Welfare (MHLW) approved once-daily Ultibro® Inhalation Capsules (glycopyrronium 50 mcg / indacaterol 110 mcg), delivered through the Breezhaler® device, for relief of various symptoms due to airway obstruction in chronic obstructive pulmonary disease (COPD). Ultibro® Breezhaler® / Ultibro® Inhalation Capsules were developed under the name QVA149.
The Washington Post reports on one suburban Maryland health system: "A special panel in charge of finding a company to take over Prince George's County's ailing health-care system has been unable to complete a sale of the system after a two-year search ... Bidders have been interested in separate parts of the system. But the panel's mandate is to ensure the facilities are sold at the same time to prevent buyers from cherry-picking ...
› Verified 7 days ago